Institutional review boards in the university setting: review of pharmaceutical testing protocols, informed consent and ethical concerns.
D000533:Altruism; D026686:Beneficence; D016638:Critical Illness; D030881:Disclosure; D004345:Drug Industry; D017041:Ethics Committees; D028741:Ethics Committees, Clinical; D028744:Ethics Committees, Research; D035082:Federal Government; D005378:Financial Support; D006076:Government; D033161:Government Regulation; D006805:Human Experimentation; D006801:Humans; D007258:Informed Consent; D007603:Jurisprudence; D016365:Liability, Legal; D016134:Organizational Policy; D005791:Patient Care; D018579:Patient Selection; D004364:Pharmaceutical Preparations; D010820:Physicians; D011329:Prisoners; D012106:Research; D012108:Research Personnel; D035842:Research Subjects; D012306:Risk; D018570:Risk Assessment; D012926:Social Control, Formal; D012935:Social Justice; D036302:Therapeutic Human Experimentation; D014481:United States; D014483:United States Dept. of Health and Human Services; D014486:United States Food and Drug Administration; D014495:Universities; D014947:Wounds and Injuries
Biomedical and Behavioral Research; Legal Approach